AJR Click to access the Dec 2009 issue
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amaral, J. G.
Right arrow Articles by Daneman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amaral, J. G.
Right arrow Articles by Daneman, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.05.0667
AJR 2006; 187:580-583
© American Roentgen Ray Society


Original Research

Safety of Power Injector Use in Children as Measured by Incidence of Extravasation

Joao Guilherme Amaral1, Jeffrey Traubici1, Guila BenDavid1, Gail Reintamm2 and Alan Daneman1

1 Department of Diagnostic Imaging, Hospital for Sick Children, 555 University Ave., Toronto, ON M5G-1X8, Canada.
2 Department of Medical Imaging, Toronto Western Hospital, University Health Network, Toronto, ON M5T-2S8, Canada.

OBJECTIVE. The purpose of this study was to assess the safety of power injector use in peripheral IV injections for CT examinations of children by measuring the incidence of contrast extravasation and to review the management of extravasation as reported in the literature.

SUBJECTS AND METHODS. At a tertiary pediatric center, we prospectively collected data on 557 children undergoing CT with IV contrast injection by power injector through a peripheral venous line. Data collected included age, weight, angiocatheter size, location of venous access, flow rate, total contrast volume, maximum injector pressure, and incidence of extravasation. Adverse effects such as emesis, sensation of warmth, hives, and allergies and anaphylaxis also were recorded.

RESULTS. The patients' ages ranged from 13 days to 20 years (mean, 9.8 years). The size of angiocatheter most commonly used was 22 gauge (n = 443). The dorsum of the hand was the most common site of venous access (n = 373). The mean flow rate was 1.48 mL/s. When the patients were divided into groups on the basis of reaction or no reaction, statistical differences between the groups were found with respect to flow rate (p = 0.016) and pressure (p = 0.017) needed for injection. There were two episode of extravasation (0.3%), which were treated conservatively.

CONCLUSION. The use of power injectors through 18- to 24-gauge angiocatheters in children is safe when meticulous technique is used and personnel are appropriately trained. Our study showed a similar rate of extravasation as has been reported in other studies.

Keywords: children • contrast media • CT • pediatrics • power injectors • safety


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
L. F. Donnelly, J. Dickerson, and J. M. Racadio
Is Hand Injection of Central Venous Catheters for Contrast-Enhanced CT Safe in Children?
Am. J. Roentgenol., December 1, 2007; 189(6): 1530 - 1532.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.